Monday
09:00 - 15:00
Servet Hall

Cardio-Renal-Metabolic Revolution: Are You Ready?

John Buse (USA), Francesco Giorgino (Italy)
Cardiovascular-renal-metabolic management of patients with T2D: The journey so far
Eduard Montanya (Spain), Jiten Vora (UK)
Welcome and introductions

Revolution in the management of cardio-renal-metabolic risk across the continuum: Following a T2D patient, prior to an acute coronary syndrome (ACS) event Introduced by Naresh Kanumilli (primary care expert)

Subodh Verma (Canada), Mark Petrie (UK), Filip Knop (Denmark), Roopa Mehta (Mexico), David Cherney (Canada)
Part 1: Cardio-renal-metabolic general practitioner consult: Preventing complications in a recently diagnosed patient with T2D
Subodh Verma (Canada), Mark Petrie (UK), Filip Knop (Denmark), Roopa Mehta (Mexico), David Cherney (Canada)
Part 2: Five years on: Maintaining glycemic control and maximizing cardio-renal risk reduction
Mark Petrie (UK), Francesco Giorgino (Italy), David Cherney (Canada)
Part 3: Moving along the risk continuum: Managing multiple vascular complications

Revolution in the management of cardio-renal-metabolic risk across the continuum: Following a T2D patient, post ACS

Subodh Verma (Canada), Mark Petrie (UK), Filip Knop (Denmark), Roopa Mehta (Mexico), Hiddo L Heerspink (The Netherlands)
Part 4: Reducing the risk of recurrent CV events, post ACS
Subodh Verma (Canada), Mark Petrie (UK), Filip Knop (Denmark), Roopa Mehta (Mexico), Hiddo L Heerspink (The Netherlands)
Part 5: Preventing further cardio-renal decline
John Buse (USA), Subodh Verma (Canada), Mark Petrie (UK), Hiddo L Heerspink (The Netherlands)
Summary and overview: Optimizing therapy for risk mitigation across the cardio-renal-metabolic continuum
John Buse (USA), Francesco Giorgino (Italy)
Cardio-renal-metabolic risk minimization in T2D: The revolution
Eduard Montanya (Spain), Jiten Vora (UK)
Summary and close
Symposium by: